Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 33 studies | 56% ± 18% | |
| capillary endothelial cell | 16 studies | 52% ± 18% | |
| endothelial cell of artery | 13 studies | 68% ± 21% | |
| vein endothelial cell | 13 studies | 53% ± 21% | |
| endothelial cell of vascular tree | 10 studies | 46% ± 22% | |
| endothelial cell of lymphatic vessel | 6 studies | 28% ± 9% | |
| glomerular endothelial cell | 4 studies | 47% ± 12% | |
| fibroblast | 3 studies | 22% ± 5% |
Insufficient scRNA-seq data for expression of CLEC14A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 3552.39 | 653 / 653 | 99% | 64.90 | 600 / 605 |
| breast | 100% | 5417.00 | 459 / 459 | 98% | 33.94 | 1093 / 1118 |
| lung | 100% | 6125.33 | 576 / 578 | 96% | 29.70 | 1106 / 1155 |
| prostate | 96% | 1599.24 | 234 / 245 | 95% | 22.67 | 478 / 502 |
| bladder | 100% | 1990.29 | 21 / 21 | 89% | 19.33 | 449 / 504 |
| kidney | 98% | 1467.16 | 87 / 89 | 90% | 92.47 | 808 / 901 |
| esophagus | 94% | 1801.42 | 1365 / 1445 | 87% | 17.48 | 159 / 183 |
| intestine | 97% | 1656.05 | 940 / 966 | 83% | 16.58 | 437 / 527 |
| adrenal gland | 86% | 890.75 | 223 / 258 | 93% | 46.05 | 215 / 230 |
| stomach | 89% | 1134.39 | 321 / 359 | 90% | 21.66 | 257 / 286 |
| uterus | 100% | 3242.84 | 170 / 170 | 76% | 16.74 | 347 / 459 |
| skin | 76% | 1097.05 | 1374 / 1809 | 82% | 15.45 | 385 / 472 |
| brain | 56% | 476.85 | 1470 / 2642 | 96% | 20.29 | 677 / 705 |
| ovary | 62% | 873.32 | 112 / 180 | 81% | 11.25 | 349 / 430 |
| pancreas | 31% | 232.25 | 103 / 328 | 99% | 36.07 | 177 / 178 |
| liver | 29% | 202.71 | 66 / 226 | 92% | 24.39 | 374 / 406 |
| adipose | 100% | 6334.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1744.13 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.37 | 1 / 1 |
| heart | 100% | 3172.05 | 858 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 1696.20 | 784 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 15.58 | 28 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 91% | 15.13 | 41 / 45 |
| blood vessel | 87% | 1723.26 | 1161 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 43% | 4.78 | 34 / 80 |
| peripheral blood | 0% | 4.59 | 3 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0002042 | Biological process | cell migration involved in sprouting angiogenesis |
| GO_0036324 | Biological process | vascular endothelial growth factor receptor-2 signaling pathway |
| GO_0001946 | Biological process | lymphangiogenesis |
| GO_0016477 | Biological process | cell migration |
| GO_0036325 | Biological process | vascular endothelial growth factor receptor-3 signaling pathway |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0062023 | Cellular component | collagen-containing extracellular matrix |
| GO_1990430 | Molecular function | extracellular matrix protein binding |
| GO_0050840 | Molecular function | extracellular matrix binding |
| GO_0030246 | Molecular function | carbohydrate binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CLEC14A |
| Protein name | C-type lectin domain family 14 member A (Epidermal growth factor receptor 5) (EGFR-5) |
| Synonyms | C14orf27 UNQ236/PRO269 EGFR5 |
| Description | |
| Accessions | ENST00000342213.3 Q86T13 |
